SWOG Cancer Research Network: all 339 studies

Page 3 of 4. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and PrednisoneCompletedNCT00933127
• SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast CancerCompletedNCT00929591Phase 3
• S9925: Collecting and Storing Samples From Patients With Lung CancerCompletedNCT00920010
• S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerCompletedNCT00919425
• S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.CompletedNCT00919139
• SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's LymphomaCompletedNCT00900484
• S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or PlasmacytomaCompletedNCT00900263
• SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney CancerCompletedNCT00900042
• S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid LeukemiaCompletedNCT00899743
• S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid LeukemiaCompletedNCT00899171
• SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical TrialCompletedNCT00898872
• S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic MelanomaCompletedNCT00898183
• S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood DiseaseCompletedNCT00898066
• S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and FluorouracilCompletedNCT00897091
• S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911CompletedNCT00896922
• S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313CompletedNCT00896727
• SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897CompletedNCT00896623
• S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesCompletedNCT00874211
• S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307WithdrawnNCT00873808
• S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid TumorsWithdrawnNCT00788580Phase 1
• S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom MacroglobulinemiaWithdrawnNCT00723658Phase 2
• S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00450281
• S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00352443Phase 1
• S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWithdrawnNCT00311545Phase 2
• S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneWithdrawnNCT00301886Phase 3
• S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPTTerminatedNCT00288106
• S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the OropharynxTerminatedNCT00268372Phase 3
• S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in RemissionWithdrawnNCT00227474Phase 2
• S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerWithdrawnNCT00217659Phase 2
• S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNCT00118105Phase 2
• S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary PlasmacytomaTerminatedNCT00109889Phase 2
• S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic ChondrosarcomaCompletedNCT00107419Phase 2
• S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00104988Phase 2
• Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial SarcomaCompletedNCT00104949Phase 2
• Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCompletedNCT00103233Phase 3
• S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the BoneCompletedNCT00096213Phase 2
• S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWithdrawnNCT00095641Phase 2
• S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung CancerTerminatedNCT00090961Not applicable
• S0400, FR901228 in Treating Patients With Advanced Cancer of the UrotheliumTerminatedNCT00087295Phase 2
• S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00085501Phase 2
• S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerWithdrawnNCT00084435Phase 2
• FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerCompletedNCT00077337Phase 2
• S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas CancerCompletedNCT00075686Phase 3
• S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung CancerTerminatedNCT00074295Phase 2
• S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the CervixWithdrawnNCT00072540Phase 2
• S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
• Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyCompletedNCT00068289Phase 2
• S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00066794Phase 2
• S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyCompletedNCT00066612Phase 2
• S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)TerminatedNCT00058448Phase 2
• S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerCompletedNCT00058318Phase 2
• S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerWithdrawnNCT00057928Phase 3
• S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNCT00055835Phase 2
• S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054054Phase 2
• S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerTerminatedNCT00053833Phase 2
• S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionCompletedNCT00049400Phase 1
• S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedCompletedNCT00049335Phase 2
• S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00049179Phase 2
• S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung CancerTerminatedNCT00045617Phase 2
• S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian CancerCompletedNCT00043082Phase 3
• Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00042783Phase 2
• Arsenic Trioxide in Treating Men With Germ Cell CancerCompletedNCT00036842Phase 2
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00032123Phase 2
• S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone SurgeryTerminatedNCT00032084Phase 3
• S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerCompletedNCT00031772Not applicable
• S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00030433Phase 2
• Interferon Alfa and Thalidomide in Treating Patients With Stage IV MelanomaCompletedNCT00026520Phase 2
• S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00026156Phase 2
• S0029 Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00025493Phase 2
• S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00023777Phase 2
• S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian CancerTerminatedNCT00023634Phase 1
• S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or ThroatTerminatedNCT00017173Phase 2
• S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or GliosarcomaCompletedNCT00017147Phase 3
• BMS-247550 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00016965Phase 2
• Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00016939Phase 2
• S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00016419Phase 2
• S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast CancerCompletedNCT00016406Phase 3
• BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00016393Phase 2
• S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00015938Phase 2
• S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung CancerTerminatedNCT00014196Phase 2
• S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00014144Phase 2
• S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusCompletedNCT00012363Phase 2
• S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or ThroatTerminatedNCT00006994Phase 3
• S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00006708Phase 3
• S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung CancerCompletedNCT00006487Phase 1
• Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00006484Phase 3
• S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00006248Phase 2
• S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic LeukemiaCompletedNCT00006020Phase 2
• S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast CancerTerminatedNCT00005983Phase 3
• S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast CancerCompletedNCT00005975Phase 3
• S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid LeukemiaCompletedNCT00005866Phase 3
• S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple MyelomaTerminatedNCT00005834Phase 3
• S9923 R115777 in Treating Patients With Advanced Colorectal CancerCompletedNCT00005833Phase 2
• S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00005832Phase 2
• S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal TumorsCompletedNCT00005597Phase 2
• S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's DiseaseTerminatedNCT00005090Phase 3
• S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaCompletedNCT00005089Phase 2
• S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or StomachCompletedNCT00004233Phase 2
• S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00004217Phase 2
• S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004137Phase 2

← SWOG Cancer Research Network overview and focus areas